The impact of current use of hormone replacement therapy on prognostic factors and surgical treatment of new breast cancers.

  • Authors:
    • A J Stolier
    • R Mera
    • D Schapira
  • View Affiliations

  • Published online on: January 1, 1998     https://doi.org/10.3892/or.5.1.61
  • Pages: 61-65
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

When postmenopausal women were diagnosed with breast cancer while taking hormone replacement, no adverse effects were noted in either clinical or prognostic factors when compared to a similar group not on hormones. Younger age at diagnosis and an increased chance of carcinoma in situ were noted in those on hormones. A surveillance or observational bias is one explanation for these findings. A promotional effect of hormone replacement therapy could not be eliminated based on this study.

Related Articles

Journal Cover

January 1998
Volume 5 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Stolier, A., Mera, R., & Schapira, D. (1998). The impact of current use of hormone replacement therapy on prognostic factors and surgical treatment of new breast cancers.. Oncology Reports, 5, 61-65. https://doi.org/10.3892/or.5.1.61
MLA
Stolier, A., Mera, R., Schapira, D."The impact of current use of hormone replacement therapy on prognostic factors and surgical treatment of new breast cancers.". Oncology Reports 5.1 (1998): 61-65.
Chicago
Stolier, A., Mera, R., Schapira, D."The impact of current use of hormone replacement therapy on prognostic factors and surgical treatment of new breast cancers.". Oncology Reports 5, no. 1 (1998): 61-65. https://doi.org/10.3892/or.5.1.61